Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Bitcoin

Bitcoin’s September Showdown: Institutional Momentum Versus Seasonal Pressure

Robert Sasse by Robert Sasse
September 3, 2025
in Bitcoin, Blockchain, ETF, Market Commentary, Trading & Momentum
0
Bitcoin Stock
0
SHARES
209
VIEWS
Share on FacebookShare on Twitter

As Bitcoin enters September 2025, it faces a well-documented historical challenge. This month has traditionally been the weakest performing period for the cryptocurrency, posting average losses of -3.77%. However, a powerful new force has entered the equation: billions of dollars in institutional capital flowing through Bitcoin ETFs. This sets the stage for a compelling battle between established seasonal patterns and evolving market structure.

Institutional Inflows Defy Historical Trends

The gravitational pull of historical performance appears to have little effect on institutional appetite. On September 3 alone, BlackRock’s IBIT Bitcoin ETF recorded substantial inflows totaling $72.9 million. The collective holdings across all Bitcoin ETFs have now surpassed 1.47 million BTC, representing a significant 7% of Bitcoin’s total circulating supply.

This institutional confidence follows a period of notable pressure in August, when aggregate outflows reached $751 million across all Bitcoin ETFs. These contrasting movements highlight the inherent volatility within institutional cryptocurrency investments and help explain the price pressure witnessed in recent weeks.

On-Chain Metrics Present Mixed Signals

While ETF flows suggest growing institutional optimism, blockchain data reveals a more complex narrative. The adjusted transfer volume has declined by 13%, dropping from a monthly average of $26.7 billion to $23.2 billion. According to analysts at Glassnode, a further decline below the yearly average of $21.6 billion could signal “weakening speculative activity.”

Simultaneously, long-term Bitcoin holders are realizing profits at levels second only to previous cycle peaks. This profit-taking behavior among traditionally steadfast investors is creating additional downward pressure on prices.

Should investors sell immediately? Or is it worth buying Bitcoin?

Confronting the September Curse

Historical data presents a clear pattern: Bitcoin has declined in value during September in 9 of the past 14 years, with average losses reaching 12%. This consistent underperformance has established September as a period of heightened investor anxiety.

The 2025 landscape differs significantly from previous years. The emergence of robust institutional infrastructure, increasing regulatory clarity, and evolving market dynamics may collectively counteract—or potentially override—these traditional seasonal weaknesses.

Critical Technical Levels in Focus

From a technical analysis perspective, Bitcoin approaches a decisive juncture. The support zone between $108,000 and $110,000 represents a critical foundation for future price action. A decisive breakout above $118,000 could signal renewed bullish momentum, while a breakdown below current support levels might test the psychologically significant $100,000 threshold.

Despite prevailing uncertainty, trading volume remains robust at $143 billion, indicating healthy market liquidity. The combination of sustained institutional participation and ongoing retail engagement underscores Bitcoin’s broad market appeal.

The coming weeks will determine whether Bitcoin’s evolving fundamental structure can overcome its historical seasonal tendencies, or if the September effect will persist even in this new era of institutional adoption.

Ad

Bitcoin Stock: Buy or Sell?! New Bitcoin Analysis from February 8 delivers the answer:

The latest Bitcoin figures speak for themselves: Urgent action needed for Bitcoin investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.

Bitcoin: Buy or sell? Read more here...

Tags: Bitcoin
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Chicago Atlantic Real Estate Finance Stock
Analysis

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

February 8, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Communications Stock
Industrial

The Race to Rewire: Fiber Optics Reshape the Telecom Landscape

February 7, 2026
Next Post
DroneShield Stock

DroneShield Shares: A Growth Story Taking Flight Despite Recent Pullback

SAP Stock

SAP's $20 Billion Bet on European Digital Sovereignty

Thyssenkrupp Stock

European Steel Giant Faces Existential Threat from Subsidized Imports

Recommended

Amgen Stock

Amgen’s Market Paradox: Strong Fundamentals Clash With Stock Performance

4 months ago
Adobe Stock

Adobe Shares Plunge to New Depths Amid Institutional Sell-Off

3 months ago
Omv Stock

OMV Shares Stabilize as Romanian Power Plant Resumes Operations

2 months ago
MKL stock news

Lynch Asset Management Inc. Decreases Stake in The Cigna Group, Analysts Offer Mixed Ratings and Price Targets

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

SuRo Capital Sharpens Focus on AI Infrastructure Investments

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

Trending

Tilray Stock
Analysis

Tilray’s Diversification Strategy Gains Momentum with Key Operational Wins

by Jackson Burston
February 8, 2026
0

Tilray Brands, Inc. continues to build on its strong January performance with two significant strategic developments. The...

Ammo Stock

Outdoor Holding Company’s Pivot Faces Crucial Quarterly Test

February 8, 2026
Berry Petroleum Stock

California Resources Navigates Post-Merger Integration and Regulatory Landscape

February 8, 2026
KemPharm Stock

Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion

February 8, 2026
Oak Valley Stock

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tilray’s Diversification Strategy Gains Momentum with Key Operational Wins
  • Outdoor Holding Company’s Pivot Faces Crucial Quarterly Test
  • California Resources Navigates Post-Merger Integration and Regulatory Landscape

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com